• Subscribe
  • Log In
  • Home
  • Daily Diary
  • Asset Class
    • U.S. Equity
    • Fixed Income
    • Global Equity
    • Commodities
    • Currencies
  • Sector
    • Basic Materials
    • Consumer Discretionary
    • Consumer Staples
    • Energy
    • Financial Services
    • Healthcare
    • Industrials
    • Real Estate
    • Technology
    • Telecom Services
    • Transportation
    • Utilities
  • Latest
    • Articles
    • Video
    • Columnist Conversations
    • Best Ideas
    • Stock of the Day
  • Street Notes
  • Authors
    • Bruce Kamich
    • Doug Kass
    • Jim "Rev Shark" DePorre
    • Helene Meisler
    • Jonathan Heller
    • - See All -
  • Options
  • RMPIA
  • Switch Product
    • Action Alerts PLUS
    • Quant Ratings
    • Real Money
    • Real Money Pro
    • Retirement
    • Stocks Under $10
    • TheStreet
    • Top Stocks
    • Trifecta Stocks
  1. Home
  2. / Investing
  3. / U.S. Equity

Traders Stick With What's Working

Big-cap momentum names are among the few that are producing results right now.
By JAMES "REV SHARK" DEPORRE
Sep 21, 2011 | 10:21 AM EDT
Stocks quotes in this article: AAPL, CMG, AMZN, GOOG, EXK, JAG, PCYC

We have very random action this morning, which isn't too surprising, as most everything is on hold until the Fed announcement this afternoon.

One thing that isn't random is the continued interest in the big-cap momentum names such as Apple (AAPL), Amazon (AMZN), Google (GOOG), Chipotle Mexican Grill (CMG), etc. Market players are sticking with that theme, and who can blame them when it is about the only thing that is really working?

Breadth is slightly positive, and we have a little upside in retailers and chips. Gold, banks, steel, coal and commodities are lagging.

Although gold is trading down, I like the way that miners are holding up. The group will definitely move on the Fed announcement, so it's tough to be too aggressive, but I'm inclined to add and have nibbled at some Endeavour Silver (EXK), a silver miner. Jaguar Mining (JAG), my stock of the week, continues to look promising but needs to clear a big seller at the $6.60 level.

I'm adding to Pharmacyclics (PCYC), a thin drug play I've mentioned a couple times, as it working to move through resistance at $12 but it needs better volume to jump-start the momentum.

Right now, I'm mostly working on a list of stocks that I will be interesting in trading after the Fed news is out. Individual stock-picking will work much better once the big macro news is out the way.

Get an email alert each time I write an article for Real Money. Click the "+Follow" next to my byline to this article.

Long PCYC, EXK and JAG, but positions will change at any time.  

TAGS: Investing | U.S. Equity

More from U.S. Equity

More Upside Potential Exists for This Market

Guy Ortmann
May 16, 2022 10:28 AM EDT

Let's take a close look at the charts and indicators.

A 'Mag'nificent Way to Play an AdTech Rebound

Bret Jensen
May 15, 2022 9:15 PM EDT

Similar to biotech, the small adtech space has been hammered in recent quarters and has likely hit oversold territory.

10 'Benjamin Graham Defensive' Stocks Make That Make the Grade

Jonathan Heller
May 13, 2022 12:00 PM EDT

This is the largest list of qualifiers since the pandemic began.

Here's Why the Potential for a Tradable Rally Has Increased

Guy Ortmann
May 13, 2022 9:42 AM EDT

The Nasdaq 1000 has now retraced 50% of its gains from the Covid low.

3 Dividend Aristocrats for Risk-Averse Investors

Bob Ciura
May 12, 2022 2:38 PM EDT

We like these high-quality stocks for their dividend safety, above-market yields, and dividend longevity.

Real Money's message boards are strictly for the open exchange of investment ideas among registered users. Any discussions or subjects off that topic or that do not promote this goal will be removed at the discretion of the site's moderators. Abusive, insensitive or threatening comments will not be tolerated and will be deleted. Thank you for your cooperation. If you have questions, please contact us here.

Email

CANCEL
SUBMIT

Email sent

Thank you, your email to has been sent successfully.

DONE

Oops!

We're sorry. There was a problem trying to send your email to .
Please contact customer support to let us know.

DONE

Please Join or Log In to Email Our Authors.

Email Real Money's Wall Street Pros for further analysis and insight

Already a Subscriber? Login

Columnist Conversation

  • 07:14 PM EDT PAUL PRICE

    A New, Very Scary Movie

  • 08:51 AM EDT PAUL PRICE

    Advice From the Future...

  • 12:20 PM EDT PAUL PRICE

    A Blast From the Past Regarding Bitcoin

  • See More

COLUMNIST TWEETS

  • A Twitter List by realmoney
About Privacy Terms of Use

© 1996-2022 TheStreet, Inc., 225 Liberty Street, 27th Floor, New York, NY 10281

Need Help? Contact Customer Service

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data & Company fundamental data provided by FactSet. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by FactSet Digital Solutions Group.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

FactSet calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.

Compare Brokers

Please Join or Log In to manage and receive alerts.

Follow Real Money's Wall Street Pros to receive real-time investing alerts

Already a Subscriber? Login